Body composition testing reveals that many of these patients are losing significant skeletal muscle mass, effectively depleting their metabolic engines despite reaching a "normal" BMI
While medications approved for the treatment of type 2 diabetes have led to weight loss, they are not approved for off-label use, such as weight loss
Semaglutide is a synthetic version of the GLP-1 hormone that is naturally produced in your intestines
FDA concerns about unapproved GLP-1 drugs describe safety and sourcing concerns
To get it approved, you would need to: Buy the patent (its for sale) Figure out a specific disease indication to apply for BPC-157 approval Hire a research team to run phase 1, 2, 3 trials The financial incentives make it so that BPC-157 will likely never go through the full FDA approval process, which is a shame given how promising this compound is
Food and Drug Administration (FDA)-approved for the treatment of type 2 diabetes and for long-term weight management